By NewsDesk @infectiousdiseasenews
Health officials in Brazil reported an additional 38,693 COVID-19 cases Saturday, bringing the total cases to 1,313,667.
More than 700,000 people have recovered and the death toll has eclipsed 57,000.
Today, the federal government entered into a partnership to produce vaccine against COVID-19. The agreement provides for the purchase of vaccine lots and technology transfer. If demonstrated to be effective, 100 million doses will be available to the Brazilian population.
The vaccine is developed by the University of Oxford and AstraZeneca, being one of the most promising in the world. In Brazil, the technology will be developed by Fiocruz (Fundação Oswaldo Cruz), foundation of the Ministry of Health. For the executive secretary of the Ministry of Health, Elcio Franco, the bilateral partnership places Brazil in the lead in the development of the vaccine against the coronavirus.
“After the agreement, the country reinforces its contribution to the world in the development of a definitive response to the pandemic and reaffirms its commitment to saving lives”, highlighted the secretary.
Lastly, officials announced the receipt of the first 200 ventilators donated by the United States government. This is the first batch of a total of a thousand that will be sent to Brazil to support the care of the Brazilian population in the fight against Covid-19.
The equipment is a strategic input used in Intensive Care Units (ICU) and will be distributed according to the demand of states and municipalities, taking into account the variation of the epidemiological curve and the structure for installation.
- Japanese encephalitis in Taiwan: 4th case reported , vaccinations advised
- Thailand chikungunya cases double in past month
- New Jersey: Study shows RMSF rare in the state
- Malaysia: Japanese Encephalitis reported in Penang, 1st cases in two years
- Plague cases rise in Ituri, DRC
- Finland COVID-19 cases continue decline
